The Pattern and Progression of “Usual” Interstitial Pneumonia with Autoimmune Features: Comparison with Patients with Classic Interstitial Pneumonia with Autoimmune Features and Idiopathic Pulmonary Fibrosis
Authors:
- Alessandro LibraALAlessandro Libra
- Michele ColaciMCMichele Colaci
- Lucia SpicuzzaLSLucia Spicuzza
- Giuliana LucaGLGiuliana Luca
- Sefora FischettiSFSefora Fischetti
- Giorgio PashalidisGPGiorgio Pashalidis
- Chiara Alfia FerraraCFChiara Alfia Ferrara
- Giuseppe IeloGIGiuseppe Ielo
- Domenico SambataroDSDomenico Sambataro
- Giuliana La RosaGRGiuliana La Rosa
- Federica LibraFLFederica Libra
- Stefano PalmucciStefano Palmucci
Open Access
- 10 January 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (2) , 369
Abstract
Background: We proposed the term “UIPAF” to define patients with Usual Interstitial Pneumonia (UIP) associated with only one domain of the classification called “Interstitial Pneumonia with Autoimmune Features” (IPAF). The objective of this study was to evaluate the clinical presentation and prognosis of UIPAF patients, compared with two cohorts, composed of IPAF and idiopathic pulmonary fibrosis (IPF) patients, respectively. Methods: The patients were enrolled as IPAF, UIPAF, or IPF based on clinical, serological, and radiological data and evaluated by a multidisciplinary team. Results: We enrolled 110 patients with IPF, 69 UIPAF, and 123 IPAF subjects. UIPAF patients were similar to IPAF regarding autoimmune features, except for the prevalence of Rheumatoid Factor in UIPAF and anti-SSA in IPAF. A similar proportion of the two cohorts progressed toward a specific autoimmune disease (SAD), with differences in the kind of SAD developed. The real-life management and prognosis of UIPAF patients proved to be almost identical to IPF. Conclusions: UIPAF shared with IPAF similar autoimmune features, suggesting the opportunity to be considered IPAF, excluding the morphological domain by the classification. However, the real-life management and prognosis of UIPAF are similar to IPF. These data suggest a possible modification in the therapeutic management of UIPAF.Keywords
This publication has 49 references indexed in Scilit:
- Idiopathic interstitial pneumonias with connective tissue diseases features: A reviewRespirology, 2015
- An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresEuropean Respiratory Journal, 2015
- 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiativeAnnals of the Rheumatic Diseases, 2013
- Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary FibrosisNew England Journal of Medicine, 2012
- Classification of rheumatoid arthritis: Comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteriaArthritis & Rheumatism, 2010
- Interstitial Lung Disease Associated With the Idiopathic Inflammatory MyopathiesChest, 2010
- 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeAnnals of the Rheumatic Diseases, 2010
- Interstitial lung disease: are we missingformes frustesof connective tissue disease?European Respiratory Journal, 2006
- High-Dose Acetylcysteine in Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2005
- ATS Statement: Guidelines for the Six-Minute Walk TestAmerican Journal of Respiratory and Critical Care Medicine, 2002